Detalles de la búsqueda
1.
Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer.
Ann Oncol
; 25(2): 409-15, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24368400
2.
A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer.
Ann Oncol
; 23(8): 2094-2102, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22345119
3.
Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study.
Technol Cancer Res Treat
; 7(6): 441-7, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19044323
4.
Dosing to rash: a phase II trial of the first-line erlotinib for patients with advanced non-small-cell lung cancer an Eastern Cooperative Oncology Group Study (E3503).
Eur J Cancer
; 50(2): 302-8, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246704
5.
Capecitabine and oxaliplatin in combination as first- or second-line therapy for metastatic breast cancer: a Wisconsin Oncology Network trial.
Cancer Chemother Pharmacol
; 71(3): 613-8, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23228989
6.
Aminoglycoside dosing weight correction factors for patients of various body sizes.
Antimicrob Agents Chemother
; 39(2): 545-8, 1995 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-7726530
Resultados
1 -
6
de 6
1
Próxima >
>>